Moreover, the use of de novo protein synthesis inhibitor cycloheximide (CHX) to detect the DDX21 turnover rate demonstrated that the DDX21 degradation rate was slowed down in gastric cancer cells overexpressing TRIP13 (Fig. 6J). This evidence concerns the gene DDX21 and gastric cancer.